Cellebrite DI (CLBT) Total Non-Current Liabilities: 2020-2025
Historic Total Non-Current Liabilities for Cellebrite DI (CLBT) over the last 4 years, with Sep 2025 value amounting to $69.7 million.
- Cellebrite DI's Total Non-Current Liabilities rose 20.18% to $69.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.7 million, marking a year-over-year increase of 20.18%. This contributed to the annual value of $59.0 million for FY2024, which is 75.89% down from last year.
- Per Cellebrite DI's latest filing, its Total Non-Current Liabilities stood at $69.7 million for Q3 2025, which was up 0.98% from $69.0 million recorded in Q2 2025.
- Cellebrite DI's Total Non-Current Liabilities' 5-year high stood at $359.5 million during Q2 2024, with a 5-year trough of $41.4 million in Q3 2021.
- Moreover, its 3-year median value for Total Non-Current Liabilities was $168.6 million (2023), whereas its average is $165.9 million.
- Per our database at Business Quant, Cellebrite DI's Total Non-Current Liabilities surged by 466.45% in 2021 and then crashed by 81.76% in 2025.
- Over the past 5 years, Cellebrite DI's Total Non-Current Liabilities (Quarterly) stood at $226.6 million in 2021, then tumbled by 46.30% to $121.7 million in 2022, then skyrocketed by 101.27% to $244.8 million in 2023, then crashed by 75.89% to $59.0 million in 2024, then increased by 20.18% to $69.7 million in 2025.
- Its last three reported values are $69.7 million in Q3 2025, $69.0 million for Q2 2025, and $58.6 million during Q1 2025.